Yesterday’s third-quarter results will not reverse the trend. Sales are down and the EBITDA margin target – already hardly ambitious – has been abandoned. As it is, the Swedish group’s colossal R&D expenditure remains a bottomless pit.
Three years ago, after a long period of underperformance, w…
© MarketScreener.com 2023
Three years ago, after a long period of underperformance, w…
© MarketScreener.com 2023